A cocktail of two antibodies might be enough to combat most varieties of influenza A, the virus behind seasonal flu and flu pandemics, a study suggests (Science, DOI: 10.1126/science.1204839). The combination approach could lead to a universal flu vaccine, a long-standing goal in an area where new vaccines must be developed each year by predicting which types of flu will dominate the coming . . .